Cargando…

One‐step CRISPR/Cas9 method for the rapid generation of human antibody heavy chain knock‐in mice

Here, we describe a one‐step, in vivo CRISPR/Cas9 nuclease‐mediated strategy to generate knock‐in mice. We produced knock‐in (KI) mice wherein a 1.9‐kb DNA fragment bearing a pre‐arranged human B‐cell receptor heavy chain was recombined into the native murine immunoglobulin locus. Our methodology re...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Ying‐Cing, Pecetta, Simone, Steichen, Jon M, Kratochvil, Sven, Melzi, Eleonora, Arnold, Johan, Dougan, Stephanie K, Wu, Lin, Kirsch, Kathrin H, Nair, Usha, Schief, William R, Batista, Facundo D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6138433/
https://www.ncbi.nlm.nih.gov/pubmed/30087111
http://dx.doi.org/10.15252/embj.201899243
_version_ 1783355346390089728
author Lin, Ying‐Cing
Pecetta, Simone
Steichen, Jon M
Kratochvil, Sven
Melzi, Eleonora
Arnold, Johan
Dougan, Stephanie K
Wu, Lin
Kirsch, Kathrin H
Nair, Usha
Schief, William R
Batista, Facundo D
author_facet Lin, Ying‐Cing
Pecetta, Simone
Steichen, Jon M
Kratochvil, Sven
Melzi, Eleonora
Arnold, Johan
Dougan, Stephanie K
Wu, Lin
Kirsch, Kathrin H
Nair, Usha
Schief, William R
Batista, Facundo D
author_sort Lin, Ying‐Cing
collection PubMed
description Here, we describe a one‐step, in vivo CRISPR/Cas9 nuclease‐mediated strategy to generate knock‐in mice. We produced knock‐in (KI) mice wherein a 1.9‐kb DNA fragment bearing a pre‐arranged human B‐cell receptor heavy chain was recombined into the native murine immunoglobulin locus. Our methodology relies on Cas9 nuclease‐induced double‐stranded breaks directed by two sgRNAs to occur within the specific target locus of fertilized oocytes. These double‐stranded breaks are subsequently repaired via homology‐directed repair by a plasmid‐borne template containing the pre‐arranged human immunoglobulin heavy chain. To validate our knock‐in mouse model, we examined the expression of the KI immunoglobulin heavy chains by following B‐cell development and performing single B‐cell receptor sequencing. We optimized this strategy to generate immunoglobulin KI mice in a short amount of time with a high frequency of homologous recombination (30–50%). In the future, we envision that such knock‐in mice will provide much needed vaccination models to evaluate immunoresponses against immunogens specific for various infectious diseases.
format Online
Article
Text
id pubmed-6138433
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-61384332018-09-15 One‐step CRISPR/Cas9 method for the rapid generation of human antibody heavy chain knock‐in mice Lin, Ying‐Cing Pecetta, Simone Steichen, Jon M Kratochvil, Sven Melzi, Eleonora Arnold, Johan Dougan, Stephanie K Wu, Lin Kirsch, Kathrin H Nair, Usha Schief, William R Batista, Facundo D EMBO J Resource Here, we describe a one‐step, in vivo CRISPR/Cas9 nuclease‐mediated strategy to generate knock‐in mice. We produced knock‐in (KI) mice wherein a 1.9‐kb DNA fragment bearing a pre‐arranged human B‐cell receptor heavy chain was recombined into the native murine immunoglobulin locus. Our methodology relies on Cas9 nuclease‐induced double‐stranded breaks directed by two sgRNAs to occur within the specific target locus of fertilized oocytes. These double‐stranded breaks are subsequently repaired via homology‐directed repair by a plasmid‐borne template containing the pre‐arranged human immunoglobulin heavy chain. To validate our knock‐in mouse model, we examined the expression of the KI immunoglobulin heavy chains by following B‐cell development and performing single B‐cell receptor sequencing. We optimized this strategy to generate immunoglobulin KI mice in a short amount of time with a high frequency of homologous recombination (30–50%). In the future, we envision that such knock‐in mice will provide much needed vaccination models to evaluate immunoresponses against immunogens specific for various infectious diseases. John Wiley and Sons Inc. 2018-08-07 2018-09-14 /pmc/articles/PMC6138433/ /pubmed/30087111 http://dx.doi.org/10.15252/embj.201899243 Text en © 2018 The Authors Open access.
spellingShingle Resource
Lin, Ying‐Cing
Pecetta, Simone
Steichen, Jon M
Kratochvil, Sven
Melzi, Eleonora
Arnold, Johan
Dougan, Stephanie K
Wu, Lin
Kirsch, Kathrin H
Nair, Usha
Schief, William R
Batista, Facundo D
One‐step CRISPR/Cas9 method for the rapid generation of human antibody heavy chain knock‐in mice
title One‐step CRISPR/Cas9 method for the rapid generation of human antibody heavy chain knock‐in mice
title_full One‐step CRISPR/Cas9 method for the rapid generation of human antibody heavy chain knock‐in mice
title_fullStr One‐step CRISPR/Cas9 method for the rapid generation of human antibody heavy chain knock‐in mice
title_full_unstemmed One‐step CRISPR/Cas9 method for the rapid generation of human antibody heavy chain knock‐in mice
title_short One‐step CRISPR/Cas9 method for the rapid generation of human antibody heavy chain knock‐in mice
title_sort one‐step crispr/cas9 method for the rapid generation of human antibody heavy chain knock‐in mice
topic Resource
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6138433/
https://www.ncbi.nlm.nih.gov/pubmed/30087111
http://dx.doi.org/10.15252/embj.201899243
work_keys_str_mv AT linyingcing onestepcrisprcas9methodfortherapidgenerationofhumanantibodyheavychainknockinmice
AT pecettasimone onestepcrisprcas9methodfortherapidgenerationofhumanantibodyheavychainknockinmice
AT steichenjonm onestepcrisprcas9methodfortherapidgenerationofhumanantibodyheavychainknockinmice
AT kratochvilsven onestepcrisprcas9methodfortherapidgenerationofhumanantibodyheavychainknockinmice
AT melzieleonora onestepcrisprcas9methodfortherapidgenerationofhumanantibodyheavychainknockinmice
AT arnoldjohan onestepcrisprcas9methodfortherapidgenerationofhumanantibodyheavychainknockinmice
AT douganstephaniek onestepcrisprcas9methodfortherapidgenerationofhumanantibodyheavychainknockinmice
AT wulin onestepcrisprcas9methodfortherapidgenerationofhumanantibodyheavychainknockinmice
AT kirschkathrinh onestepcrisprcas9methodfortherapidgenerationofhumanantibodyheavychainknockinmice
AT nairusha onestepcrisprcas9methodfortherapidgenerationofhumanantibodyheavychainknockinmice
AT schiefwilliamr onestepcrisprcas9methodfortherapidgenerationofhumanantibodyheavychainknockinmice
AT batistafacundod onestepcrisprcas9methodfortherapidgenerationofhumanantibodyheavychainknockinmice